Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are we misunderstanding beta-blockers.

J M Cruickshank1

  • 1Cambridge University, Long Melford, Suffolk CO10 9DE, United Kingdom. johndtl@aol.com

International Journal of Cardiology
|April 17, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transversely excited atmospheric CO(2) laser radar with heterodyne detection.

Applied optics·2010
Same author

New guidelines on hypertension.

Lancet (London, England)·2006
Same author

The hydration structure of guanidinium and thiocyanate ions: implications for protein stability in aqueous solution.

Proceedings of the National Academy of Sciences of the United States of America·2003
Same author

Renoprotection with antihypertensive agents.

Lancet (London, England)·2002
Same author

Beta-adrenergic blocking drugs in the treatment of hypertension.

Blood pressure·2002
Same author

Antihypertensive treatment and the J-curve.

Cardiovascular drugs and therapy·2000
Same journal

Hypertension management in obstructive hypertrophic cardiomyopathy patients treated with cardiac myosin inhibitors - real world data.

International journal of cardiology·2026
Same journal

Fully quantitative CMR rest perfusion reveals myocardial perfusion abnormality in Kawasaki disease: Association with left ventricular Remodeling.

International journal of cardiology·2026
Same journal

Predicted adherence and ischaemic stroke risk in atrial fibrillation patients initiating oral anticoagulation: A cohort study of the medication adherence score.

International journal of cardiology·2026
Same journal

Severe tricuspid regurgitation is a congestion-driven cardiorenal disease: A longitudinal study defining a right heart failure phenotype.

International journal of cardiology·2026
Same journal

Applicability of ischemic heart disease clinical practice guidelines in low- and middle-income countries.

International journal of cardiology·2026
Same journal

Effectiveness of a new diagnostic algorithm for the diagnosis of unexplained syncope in patients with hypertrophic cardiomyopathy.

International journal of cardiology·2026
See all related articles

Beta-blockers are effective for younger hypertension patients, especially with ischemia, but less so for elderly patients. Beta-1 selective agents and combination therapy with diuretics show promise in specific hypertensive populations.

Area of Science:

  • Cardiology
  • Pharmacology
  • Hypertension Management

Background:

  • Beta-blockers with intrinsic sympathomimetic activity (ISA) show poor outcomes in myocardial ischemia and heart failure.
  • Beta-1 blockade is crucial for treating heart failure, with bisoprolol as a first-line option.
  • NICE guidelines question routine initial beta-blocker therapy for hypertension, discouraging combinations with diuretics and favoring ACE-inhibitors for younger patients.

Purpose of the Study:

  • To evaluate the therapeutic role of beta-blockers in hypertension, considering age and specific patient profiles.
  • To differentiate the efficacy of various beta-blockers based on their selectivity and activity.
  • To assess the effectiveness of beta-blocker therapy in conjunction with other antihypertensives.

Main Methods:

Related Experiment Videos

  • Analysis of epidemiological data (e.g., Framingham Heart Study) to understand hypertension development in different age groups.
  • Review of clinical trial data and meta-analyses, considering factors like age and prior treatment.
  • Comparison of beta-blocker efficacy based on beta-1 selectivity, ISA, and effects on vascular compliance.

Main Results:

  • Younger hypertensives, particularly those with weight gain and high cardiac output, benefit from first-line beta-blockade in preventing myocardial infarction.
  • Elderly systolic hypertension is poorly managed with first-line beta-blockers like atenolol due to metabolic disturbances and lack of vascular compliance improvement.
  • Beta-blockers such as bisoprolol and nebivolol improve vascular compliance without metabolic side effects.
  • Combination therapy of low-dose diuretics followed by beta-blockers is effective in elderly hypertensive patients, including diabetics, reducing cardiovascular events and bone fracture risk.

Conclusions:

  • Beta-1 selective beta-blockers are vital for heart failure and beneficial for younger hypertensive patients.
  • Beta-blockers are not ideal as first-line therapy for elderly hypertension but show efficacy as second-line agents with diuretics.
  • Hypertensive patients with ischemia across all age groups are suitable candidates for beta-blockade.